Citation APA
Dieci, M. V., Radosevic-Robin, N., Fineberg, S., Van den Eynden, G., Ternes, N., Pénault-Llorca, F., Pruneri, G., D'Alfonso, T. T., Demaria, S., Castaneda, C., Sanchez, J., Badve, S., Michiels, S., Bossuyt, V. I. J., Rojo, F., Singh, B., Nielsen, T., Viale, G., Kim, S.-R., Hewitt, S. M., Wienert, S., Loibl, S., Rimm, D. D., Symmans, F., Denkert, C., Adams, S., Loi, S., Salgado, R., & International Immuno-Oncology Biomarker Working Group on Breast Cancer, (2018). Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer. Seminars in cancer biology, 52(Pt 2), 16-25. doi:10.1016/j.semcancer.2017.10.003
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/284078